- Home
- ADAG vs INGN Comparison
ADAG vs INGN Comparison
Compare ADAG & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAG | INGN |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | China | United States |
| Employees | 138 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.3M | 156.1M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ADAG | INGN |
|---|---|---|
| Price | $2.96 | $6.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.00 | ★ $11.00 |
| AVG Volume (30 Days) | 108.8K | ★ 267.9K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $335,705,000.00 |
| Revenue This Year | $3,688.61 | $12.70 |
| Revenue Next Year | $17.39 | $3.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.35 |
| 52 Week Low | $1.33 | $5.34 |
| 52 Week High | $3.53 | $9.13 |
Technical Indicators
Market Signals| Indicator | ADAG | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 49.14 |
| Support Level | $1.64 | $5.98 |
| Resistance Level | $3.19 | $6.19 |
| Average True Range (ATR) | 0.30 | 0.43 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 48.01 | 44.04 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.